In order to determine whether the primary tumor and metastases are dependent on Kras* we withdrew doxy in iKras*p53* mice, thus inactivating the Kras* transgene, and performed serial imaging of the same animal over time (scheme in Fig. 4A and Fig. 5A). This evidence concerns the gene KRAS and neoplasm.